•
Sep 30, 2022

ImmunityBio Q3 2022 Earnings Report

Total Revenue
$118K
Previous year: $66K
+78.8%
EPS
-$0.22
Previous year: -$0.22
+0.0%
Gross Profit
-$5.86M
Previous year: $66K
-8974.2%
Cash and Equivalents
$104M
Previous year: $64.5M
+61.4%
Free Cash Flow
-$96.5M
Previous year: -$80.7M
+19.6%
Total Assets
$353M
Previous year: $214M
+64.6%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment